Insider · CIK 0001164007

FRANK DANIEL

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001164007

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2010-05-13	Molecular Insight Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	−25K sh	—	—	25,000
2009-10-06	Molecular Insight Pharmaceuticals, Inc.W Will/Inheritance	Director	WWill/Inheritance	+3,679 sh	—	—	146,959
2009-05-12	Molecular Insight Pharmaceuticals, Inc.Stock option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2007-06-26	Molecular Insight Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2007-02-01	Molecular Insight Pharmaceuticals, Inc.C Conversion	Director	CConversion	+72.1K sh	—	—	72,120
2007-02-01	Molecular Insight Pharmaceuticals, Inc.C Conversion	Director	CConversion	+54.4K sh	—	—	126,487
2007-02-01	Molecular Insight Pharmaceuticals, Inc.C Conversion	Director	CConversion	+12.6K sh	—	—	139,113
2007-02-01	Molecular Insight Pharmaceuticals, Inc.Series B Convertible Preferred StockC Conversion	Director	CConversion	−1,894 sh	—	—	0
2007-02-01	Molecular Insight Pharmaceuticals, Inc.Series C Convertible Preferred StockC Conversion	Director	CConversion	−1,488 sh	—	—	0
2007-02-01	Molecular Insight Pharmaceuticals, Inc.Common Stock Purchase Warrant (right to buy)C Conversion	Director	CConversion	−12.6K sh	$3.96	−$50K	0
2004-01-28	I STAT CORPORATION /DE/U Disposition from Tender	Former Director	UDisposition from Tender	−96.2K sh	$15.35	−$1.48M	0
2002-08-02	I STAT CORPORATION /DE/P Purchase	Former Director	PPurchase	+1,000 sh	$2.89	+$2,890	—
2002-08-02	I STAT CORPORATION /DE/P Purchase	Former Director	PPurchase	+2,000 sh	$2.84	+$5,680	96,200
2002-07-31	I STAT CORPORATION /DE/P Purchase	Former Director	PPurchase	+2,000 sh	$3.20	+$6,400	93,200
2002-05-20	I STAT CORPORATION /DE/P Purchase	Former Director	PPurchase	+500 sh	$5.89	+$2,945	91,200
2002-05-16	I STAT CORPORATION /DE/P Purchase	Former Director	PPurchase	+500 sh	$5.50	+$2,750	—
2002-02-19	I STAT CORPORATION /DE/P Purchase	Former Director	PPurchase	+500 sh	$6.41	+$3,205	90,200

Recent filings

Accepted (ET)
May 174
FRANK DANIEL0001181431-10-027375
SEC(opens sec.gov)
Feb 165
FRANK DANIEL0001181431-10-009255
SEC(opens sec.gov)
May 144
FRANK DANIEL0001005477-09-002278
SEC(opens sec.gov)
Jun 284
Molecular Insight Pharmaceuticals, Inc.0001005477-07-003790
SEC(opens sec.gov)
Feb 54
Molecular Insight Pharmaceuticals, Inc.0001005477-07-000659
SEC(opens sec.gov)
Feb 104
FRANK DANIEL0001005477-04-000658
SEC(opens sec.gov)
Aug 74
I STAT CORPORATION /DE/0000905718-02-000302
SEC(opens sec.gov)
Aug 74
I STAT CORPORATION /DE/0000905718-02-000301
SEC(opens sec.gov)
Jun 44
FRANK DANIEL0000905718-02-000225
SEC(opens sec.gov)
Mar 14
FRANK DANIEL0000905718-02-000111
SEC(opens sec.gov)

Companies

Address

C/O CERBERUS CAPITAL MANAGEMENT, L.P. 299 PARK AVENUE, 22ND FLOOR

NEW YORK, NY, 10171